India’s herbal and ayurvedic OTC market set to outpace global growth
New Delhi: India’s herbal and ayurvedic OTC (over the counter) market is expected to grow at a CAGR of 6.5 per cent, from $69 million in 2025 to $118 million…
Glenmark Pharma gets USFDA nod for Acetaminophen and Ibuprofen tablets
New Delhi: Glenmark Pharmaceuticals Ltd has received final approval from the United States Food Drug Administration (USFDA) for Acetaminophen and Ibuprofen tablets, 250 mg/125 mg (OTC). The regulatory authority has…
Piramal Pharma open to partnerships in OTC; eyes further debt reduction
Piramal Pharma is open to partnerships in the over-the-counter (OTC) space in India as it charts out plans for organic growth and debt reduction. The company has been consistently reducing…









